Comparison of the possible risk factors of bone mineral density in subjects with ulcerative colitis and healthy subjects

Southern Medical Journal

Volumn 104, Issue 11, 2011, Pages 747-751

  Kaya, Gülfem ^a   Koçak, Erdem ^a   Akbal, Erdem ^a   Taş, Adnan ^a   Köklü, Seyfettin ^a  

^a ANKARA TRAINING AND RESEARCH HOSPITAL   (Turkey)

Author keywords

Bone mineral density; Inflammatory bowel disease; Ulcerative colitis

Indexed keywords

ALKALINE PHOSPHATASE; AZATHIOPRINE; CALCITRIOL; CALCIUM; CORTICOSTEROID; FOLIC ACID; IMMUNOSUPPRESSIVE AGENT; IRON; MULTIVITAMIN; OSTEOCALCIN; PARATHYROID HORMONE; VITAMIN D;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; BODY MASS; BONE DENSITY; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE DURATION; FEMALE; FEMUR NECK; HUMAN; LUMBAR VERTEBRA; MALE; MENSTRUATION; MILK; OSTEOPENIA; OSTEOPOROSIS; RISK FACTOR; SMOKING; ULCERATIVE COLITIS;

ADULT; BONE DENSITY; BONE DISEASES, METABOLIC; CASE-CONTROL STUDIES; COLITIS, ULCERATIVE; FEMALE; HUMANS; MALE; MIDDLE AGED; OSTEOPOROSIS; RISK FACTORS;

EID: 80155151118     PISSN: 00384348     EISSN: 15418243     Source Type: Journal    
DOI: 10.1097/SMJ.0b013e318232367e     Document Type: Article

References (24)

1. Liu JB, Gao X, Zhang FB, et al. The risk factor for low bone mineral density in patients with inflammatory bowel disease. Zhonghua Nei Ke Za Zhi 2009;48:833-836.
2. Zali M, Bahari A, Firouzi F, et al. Bone mineral density in Iranian patients with inflammatory bowel disease. Int J Colorectal Dis 2006;21:758-766. (Pubitemid 44524030)
3. De Silva AP, Karunanayake AL, Dissanayaka TG, et al. Osteoporosis in adult Sri Lankan inflammatory bowel disease patients. World J Gastroenterol 2009;28:3528-3531.
4. Tsironi E, Hadjidakis D, Mallas E, et al. Comparison of T- and z-score in identifying risk factors of osteoporosis in inflammatory bowel disease patients. J Musculoskelet Neuronal Interact 2008;8:79-84.
5. Ardizzone S, Bollani S, Bettica P, et al. Altered bone metabolism in inflammatory bowel disease: there is a difference between Crohn's disease and ulcerative colitis. J Intern Med 2000;247:63-70. (Pubitemid 30073165)
6. Lora FL, Amarante HM, Pisani JC, et al. Bone mineral density evaluation in inflammatory bowel disease patents. Arq Gastroenterol 2005;42:201-205. (Pubitemid 43231950)
7. Frei P, Fried M, Hungerbuhler V, et al. Analysis of risk factors for low bone mineral density in inflammatory bowel disease. Digestion 2006;73: 40-46. (Pubitemid 43800660)
8. Jahnsen J, Falch JA, Aadland E, et al. Bone mineral density is reduced in patients with Crohn's disease but not in patients with ulcerative colitis: a population based study. Gut 1997;40:313-319. (Pubitemid 27145642)
9. Vestergaard P, Krogh K, Rejnmark L, et al. Fracture risk is increased in Crohn's disease, but not in ulcerative colitis. Gut 2000;46:176-181. (Pubitemid 30305842)
10. Loftus EV Jr, Achenbach SJ, Sandborn WJ, et al. Risk of fracture in ulcerative colitis: a population-based study from Olmsted County, Minnesota. Clin Gastroenterol Hepatol 2003;1:465-473. (Pubitemid 37413610)
11. Bjarnason I, Macpherson A, Buxton-Thomas M, et al. High prevalence of osteoporosis in patients with inflammatory bowel disease and low lifetime intake of corticosteroids. Gastroenterology 1993;105:541.
12. Pollak RD, Karmeli F, Eliakim R, et al. Femoral neck osteopenia in patients with inflammatory bowel disease. Am J Gastroenterol 1998;93: 1483-1490. (Pubitemid 29075187)
13. Siffledeen JS, Fedorak RN, Siminoski K, et al. Bones and Crohn's: risk factors associated with low bone mineral density in patients with Crohn's disease. Inflamm Bowel Dis 2004;10:220-228. (Pubitemid 38618250)
14. Jahnsen J, Falch JA, Mowinckel P, et al. Bone mineral density in patients with inflammatory bowel disease: a population-based prospective twoyear follow-up study. Scand J Gastroenterol 2004;39:145-153. (Pubitemid 38253626)
15. Reffitt DM, Meenan J, Sanderson JD, et al. Bone density improves with disease remission in patients with inflammatory bowel disease. Eur J Gastroenterol Hepatol 2003;15:1267-1273. (Pubitemid 39049668)
16. Saag KG. Prevention of glucocorticoid-induced osteoporosis. South Med J 2004;97:555-558. (Pubitemid 38802769)
17. Hela S, Nihel M, Faten L, et al. Osteoporosis and Crohn's disease. Joint Bone Spine 2005;72:403-407. (Pubitemid 41415828)
18. Abitbol V, Roux C, Chaussade S, et al. Metabolic bone assessment in patients with inflammatory bowel disease. Gastroenterology 1995;108: 417-422.
19. Card T, West J, Hubbard R, et al. Hip fractures in patients with inflammatory bowel disease and their relationship to corticosteroid use: a population based cohort study. Gut 2004;53:251-255. (Pubitemid 38125514)
20. Klaus J, Armbrecht G, Steinkamp M, et al. High prevalence of osteoporotic vertebral fractures in patients with Crohn's disease. Gut 2002;51: 654-658. (Pubitemid 35216851)
21. Meier C, Woitge HW, Witte K, et al. Supplementation with oral vitamin D3 and calcium during winter prevents seasonal bone loss: a randomized controlled open-label prospective trial. J Bone Miner Res 2004;19: 1221-1230. (Pubitemid 41094362)
22. Storm D, Eslin R, Porter ES, et al. Calcium supplementation prevents seasonal bone loss and changes in biochemical markers of bone turnover in elderly New England women: a randomized placebo-controlled trial. J Clin Endocrinol Metab 1998;83:3817-3825. (Pubitemid 28513556)
23. Chapuy MC, Arlot ME, Duboeuf F, et al. Vitamin D3 and calcium to prevent hip fractures in the elderly women. N Engl J Med 1992;327: 1637-1642.
24. Ross PD, KnowltonW. Rapid bone loss is associated with increased levels of biochemical markers. J Bone Miner Res 1998;13:297-302. (Pubitemid 28082387)